Yellow Fever Vaccine. II. Antigenicity and Neurovirulence of a Vaccine Seed Free from Avian Leukosis Virus

No abstract is available for this paper.

• Publication year

  1969

• Venue

  Applied microbiology

• Publication date

  1969-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/am.17.6.866-870.1969PMID 4307883PMCID PMC377828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yellow fever virus. I. Development and evaluation of a plaque neutralization test.

  1968cited by this paper
• Yellow Fever Vaccine I. Development of a Vaccine Seed Free from Contaminating Avian Leukosis Viruses

  1968cited by this paper
• Effects of Medial Temporal Lesions on Taste Preference in the Monkey

  1960cited by this paper
• ‘Dex’ or ‘Order of Magnitude’?

  1960cited by this paper
• PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES

  1954cited by this paper
• Diagnosis of Viral and Rickettsial Infections

  1949cited by this paper
• BEHAVIOR OF 17D YELLOW FEVER VIRUS IN RHESUS MONKEYS RELATION TO SUBSTRAIN, DOSE, AND NEURAL OR EXTRANEURAL INOCULATION

  1943cited by this paper

• The Yellow Fever Outbreak in Brazil (2016–2018): How a Low Vaccination Coverage Can Contribute to Emerging Disease Outbreaks

  2025cites this paper
• Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study

  2024cites this paper
• Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model

  2024cites this paper
• YF17D‐based vaccines – standing on the shoulders of a giant

  2024cites this paper
• A Review of the Establishment of the Seed Lot System in the Production of Biological Products and Its Importance.

  2022cites this paper
• The global burden of yellow fever

  2020cites this paper
• Individualizing immunization for international travelers.

  2017cites this paper
• On the use of Gillespie stochastic simulation algorithm in a model of the human immune system response to the Yellow Fever vaccine

  2017cites this paper
• Vaccination against Viruses

  2016influential citation
• Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses

  2016cites this paper
• A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.

  2015cites this paper
• Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine

  2015cites this paper
• Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

  2015cites this paper
• Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy.

  2015cites this paper
• The niche reduction approach: an opportunity for optimal control of infectious diseases in low-income countries?

  2014cites this paper
• Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model

  2014cites this paper
• Yellow fever risk assessment in the Central African Republic.

  2014cites this paper
• Duration of post-vaccination immunity against yellow fever in adults.

  2014cites this paper
• Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data

  2014cites this paper
• Variability in the immune system: of vaccine responses and immune states.

  2013cites this paper
• Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

  2013cites this paper
• A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.

  2013cites this paper
• Molecular and immunological characterization of a DNA launched yellow fever virus 17D infectious clone

  2013cites this paper
• Yellow fever vaccination: The potential of dose-sparing to increase vaccine supply and availability.

  2013cites this paper
• Construction characterization and application of Flavivirus infectious clones

  2013cites this paper
• Yellow Fever Encephalitis: An Emerging and Resurging Global Public Health Threat in a Changing Environment

  2013cites this paper
• Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

  2013influential citation
• Vaccine administration decision making: the case of yellow fever vaccine.

  2012cites this paper
• EVOLUTION AND MEDICINE IN UNDERGRADUATE EDUCATION: A PRESCRIPTION FOR ALL BIOLOGY STUDENTS

  2012cites this paper
• Adverse reactions to vaccines practice parameter 2012 update.

  2012cites this paper
• Recombinant protein vaccines produced in insect cells

  2012cites this paper
• Balancing the Efficacy and Safety of Vaccines in the Elderly.

  2012cites this paper
• Molecular and cellular studies of mosquito odorant receptors and olfactory-driven larval behavior.

  2011cites this paper
• THE SCIENCE AND APPLICATIONS OF SYNTHETIC AND SYSTEMS BIOLOGY Workshop Summary

  2011cites this paper
• History of vaccine development

  2011cites this paper
• Systems Biology of Seasonal Influenza Vaccination in Humans

  2011cites this paper
• Vaccination of travelers: how far have we come and where are we going?

  2011cites this paper
• Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

  2011cites this paper
• The Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine

  2011cites this paper
• Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.

  2011cites this paper
• Could Autoimmunity Be Induced by Vaccination?

  2010cites this paper
• Mosquito‐Borne Illnesses in Travelers: A Review of Risk and Prevention

  2010cites this paper
• Household-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005.

  2010cites this paper
• Transmission of yellow fever vaccine virus through breast-feeding - Brazil, 2009.

  2010influential citation
• Yellow fever: a reemerging threat.

  2010cites this paper
• Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.

  2010cites this paper
• Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology

  2009cites this paper
• Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

  2009cites this paper
• Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.

  2009cites this paper
• Short report: Incidence of yellow fever vaccine-associated neurotropic disease.

  2009cites this paper
• Existing antiviral vaccines

  2009influential citation
• Wanted, dead or alive: new viral vaccines.

  2009cites this paper
• Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics.

  2009cites this paper
• Microneedle-based vaccines.

  2009cites this paper
• An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005.

  2008cites this paper
• Yellow fever vaccine: past, present and future

  2008influential citation
• Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway

  2008cites this paper
• Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.

  2008cites this paper
• Immunization issues in pediatric travelers

  2008cites this paper
• E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence

  2008cites this paper
• [Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue].

  2008cites this paper
• Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

  2008cites this paper
• Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.

  2008cites this paper
• Climate and vectorborne diseases.

  2008cites this paper
• Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes

  2007cites this paper
• Out of Africa: A Molecular Perspective on the Introduction of Yellow Fever Virus into the Americas

  2007cites this paper
• Yellow fever: epidemiology and prevention.

  2007influential citation
• Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.

  2007influential citation
• Activity of T-1106 in a Hamster Model of Yellow Fever Virus Infection

  2007cites this paper
• WHO Expert Committee on biological standardization.

  2005cites this paper
• Yellow fever vaccine

  1972cites this paper
• Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.

  1972cites this paper
• Yellow Fever Vaccine. IV. Reactogenicity and Antibody Response in Volunteers Inoculated With a Vaccine Free From Contaminating Avian Leukosis Viruses

  1972cites this paper
• Yellow Fever Vaccine. V. Antibody Response in Monkeys Inoculated with Graded Doses of the 17D Vaccine

  1972cites this paper
• Simian Hemorrhagic Fever Virus

  1971cites this paper